Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Functional MRI Examination of Visual Pathways in Patients with Unilateral Optic Neuritis.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
HMGB1 in Development and Diseases of the Central Nervous System.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Anorexia heralding the onset of neuromyelitis optica.
Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihidroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis.
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis.
Distinguishing Susac's syndrome from multiple sclerosis.
Delayed Central Nervous System Irradiation Effects in Rats - Part 2: Aggravation of Experimental Autoimmune Encephalomyelitis.
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations.
Depression in multiple sclerosis: A long-term longitudinal study.
Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.

Pages